Department of Primary and Community Care, Center for Family Medicine, Geriatric Care and Public Health, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
Int Psychogeriatr. 2011 Oct;23(8):1249-59. doi: 10.1017/S1041610211000755. Epub 2011 Jun 20.
The goal of this study is to determine patterns of psychotropic drug use (PDU), the association with neuropsychiatric symptoms (NPS), and the variability across dementia types in nursing home residents with dementia. In addition, PDU was analyzed across multiple indications.
This was a prospective cohort study over a two-year period from 2006 to 2008, which involved 14 dementia special care units in nine nursing homes. A total of 117 residents with dementia participated in the study, of whom 35% had Alzheimer's dementia (AD) and 11% vascular dementia (VaD). PDU was classified according to anatomical therapeutic chemical-classification as either "present" or "absent".
The majority of residents had moderately severe to severe dementia. At all successive assessments, almost two-thirds of residents received any psychotropic drug (PD) and almost one-third continued to receive any PD. Of all PDs, antipsychotics (APs) were prescribed most frequently. Fewer residents started with antidepressants, but continued to receive antidepressants at higher percentages. Anxiolytics showed an intermittent course, but a subgroup of 9% showed two-year continuation. Once started on PDs at baseline, residents continued to use PDs at high percentages: three-quarters continued to receive APs for at least six months. Half of residents received at least one PD; one-fifth received at least two PDs simultaneously. Residents with AD received more hypnotics and antidementia drugs; residents with VaD received more antipsychotics, antidepressants, anxiolytics and anticonvulsants.
PDs have different utilization patterns, but overall, consistently high continuation rates were found. These results warrant scrutiny of continuous PDU.
本研究旨在确定痴呆患者在疗养院中的精神药物使用(PDU)模式、与神经精神症状(NPS)的关联,以及在不同痴呆类型之间的变化。此外,还分析了 PDU 在多种适应症下的使用情况。
这是一项为期两年的前瞻性队列研究,从 2006 年到 2008 年,涉及 9 家疗养院的 14 个痴呆特殊护理单元。共有 117 名痴呆患者参与了这项研究,其中 35%患有阿尔茨海默病(AD),11%患有血管性痴呆(VaD)。PDU 根据解剖治疗化学分类分为“存在”或“不存在”。
大多数患者都有中度至重度痴呆。在所有连续评估中,几乎三分之二的患者接受了任何精神药物(PD),几乎三分之一的患者继续接受任何 PD。在所有 PD 中,抗精神病药(APs)的处方最频繁。开始服用抗抑郁药的患者较少,但继续服用的比例较高。安定药呈间歇性使用,但有 9%的亚组患者持续使用两年。一旦在基线时开始使用 PD,患者继续以高比例使用 PD:四分之三的患者至少继续使用 APs 六个月。有一半的患者至少服用一种 PD;五分之一的患者同时服用至少两种 PD。患有 AD 的患者服用了更多的催眠药和抗痴呆药物;患有 VaD 的患者服用了更多的抗精神病药、抗抑郁药、安定药和抗惊厥药。
PD 有不同的使用模式,但总体而言,发现持续使用的比例很高。这些结果值得对持续的 PDU 进行仔细审查。